Skip to main content
. 2022 Feb 5;380(2):10. doi: 10.1007/s41061-022-00365-x

Fig. 68.

Fig. 68

SAR and exploration of triazolothiadiazine derivatives as cholinesterase (ChE) and monoamine oxidase (MAO) inhibitors